Ranbaxy Laboratories, one of the leading pharma players witnessed a sharp rise in share price on Tuesday after it reported consolidated net profit of Rs 4.78 billion for the quarter ended Sept. 30, 2014 as compared to net loss of Rs 4.54 billion in the same period last year.
Total income came at Rs 32.60 billion, an increase of 16.35% over Rs 28.02 million in the same period a year ago.
Shares of the company are trading at Rs 639.80, up Rs 42.2, or 7.06% at the Bombay Stock Exchange (BSE) on Tuesday at 2:18 p.m.
The scrip has touched an intra-day high of Rs 641.90 and low of Rs 600.00. The total volume of shares traded at the BSE is 693,670.